6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one

6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one Suppliers list
Company Name: Atop-Pharma (Shanghai) Technology Co., Ltd.  
Tel: +86 (21) 5196-9732
Email:
Company Name: ShangHai KenEn Chemical Technology Co., Ltd.  
Tel: 13120367189;18621755571
Email: mychess007@163.com
Company Name: Hangzhou J&H Chemical Co., Ltd.  
Tel: 0571-87396432
Email: sales@jhechem.com
Company Name: LABTER PHARMATECH(BEIJING) CO.,LTD  
Tel: 010-56330744 18310155299
Email: sales@labter.com.cn
Company Name: Shanghai KunRaise Chemical Technology Co., Ltd  
Tel: +86-021-50935922
Email:
6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one Basic information
Product Name:6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one
Synonyms:6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one;6-Bromo-3,4-dihydro-4,4-dimethylnaphthalen-1(2H)-one;6-Bromo-4,4-dimethyl-3,4-dihydro-2H-naphthalen-1-one;1(2H)-Naphthalenone, 6-bromo-3,4-dihydro-4,4-dimethyl-;6-Bromo-4,4-dimethyl-2,3-dihydronaphthalen-1-one;6-bromo-4,4-dimethyl-1,2,3,4-tetrahydronaphthalen-1-one
CAS:98453-60-2
MF:C12H13BrO
MW:253.13
EINECS:
Product Categories:
Mol File:98453-60-2.mol
6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one Structure
6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one Chemical Properties
Melting point 48℃
Boiling point 335℃
density 1.351
Fp 75℃
storage temp. Sealed in dry,Room Temperature
Safety Information
MSDS Information
6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one Usage And Synthesis
Synthesis
7-broMo-1,1-diMethyl-1,2,3,4-tetrahydronaphthalene

98453-58-8

6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one

98453-60-2

7-Bromo-1,1-dimethyl-1,2,3,4-tetrahydronaphthalene (Compound 2, 1.1 g, 4.62 mmol) was used as a starting material and dissolved in 10 mL of dichloromethane. To this solution was added chromium (VI) oxide (72 mg, 0.46 mmol) and 5 mL of tert-butyl hydroperoxide solution (TBHP). The reaction mixture was stirred at room temperature for 8 hours. Upon completion of the reaction, the mixture was diluted with 20 mL of water and subsequently extracted with ether (3 x 10 mL). The combined organic phases were washed with brine (10 mL), dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to remove the solvent. The crude product was purified by fast chromatography (eluent ratio 90:10 hexane/ethyl acetate) to afford 6-bromo-4,4-dimethyl-3,4-dihydronaphthalen-1(2H)-one (920 mg, 79% yield) as a white solid. The product was characterized by 1H NMR (CDCl3, 300 MHz): δ 7.87 (d, J = 8.1 Hz, 1H), 7.54 (d, J = 2.1 Hz, 1H), 7.42 (dd, J = 2.1, 8.1 Hz, 1H), 2.70 (dd, J = 6.3, 7.5 Hz, 2H), 2.01 (dd, J = 6.3, 7.5 Hz, 2H), 1.38 (s, 6H).

References[1] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 13, p. 4345 - 4359
[2] Patent: WO2005/66115, 2005, A2. Location in patent: Page/Page column 19; 21
[3] Patent: US2005/148590, 2005, A1. Location in patent: Page/Page column 23; 24
[4] Tetrahedron, 1985, vol. 41, # 8, p. 1509 - 1516
[5] Patent: WO2004/46096, 2004, A2. Location in patent: Page 24
6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one Preparation Products And Raw materials
Raw materials7-broMo-1,1-diMethyl-1,2,3,4-tetrahydronaphthalene-->Dichloromethane-->tert-Butyl hydroperoxide-->Chromium(VI) oxide
Tag:6-broMo-4,4-diMethyl-3,4-dihydronaphthalen-1(2H)-one(98453-60-2) Related Product Information
6-Bromo-3,4-dihydro-4,4-dimethylquinolin-2(1H)-one 6-bromo-1,2,3,4-tetrahydro-4,4-dimethylquinoline hydrochloride 6-broMo-4,4-diMethyl-1,2,3,4-tetrahydroquinoline hydrochloride 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one